Overview
Study of 0444 Gel in the Treatment of Inflammatory Lesions of Rosacea
Status:
Completed
Completed
Trial end date:
2009-07-01
2009-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The aim of this trial is to assess the efficacy of Metronidazole Topical Gel 1% in the Treatment of Inflammatory Lesions of Rosacea. Treatment medication will be administered as follows: A thin film of gel will be applied and rubbed into the entire face once daily for a period of 70 days.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Fougera Pharmaceuticals Inc.
Criteria
Inclusion Criteria:- Clinical diagnosis of rosacea
- Good health with the exception of rosacea
- Papsules and pustules minimum and maximum requirements
Exclusion Criteria:
- Subjects who are pregnant, nursing, or planning a pregnancy within the study
participation period.
- Subjects who have any systemic or dermatological disorders with the exception of
rosacea